SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 93 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2014. The put-call ratio across all filers is 1.91 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $35,000 | -58.8% | 15,766 | -63.8% | 0.00% | -66.7% |
| Q1 2015 | $85,000 | -49.1% | 43,591 | -30.9% | 0.00% | -50.0% |
| Q4 2014 | $167,000 | -30.7% | 63,123 | -21.0% | 0.01% | -14.3% |
| Q3 2014 | $241,000 | -31.3% | 79,927 | -7.0% | 0.01% | -22.2% |
| Q2 2014 | $351,000 | +663.0% | 85,937 | +703.0% | 0.01% | +800.0% |
| Q1 2014 | $46,000 | -47.7% | 10,702 | -36.3% | 0.00% | -66.7% |
| Q4 2013 | $88,000 | +31.3% | 16,802 | +58.5% | 0.00% | +50.0% |
| Q3 2013 | $67,000 | – | 10,601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,696,894 | $7,637,000 | 32.03% |
| Anson Funds Management LP | 989,204 | $348,000 | 0.11% |
| CAXTON CORP | 62,000 | $22,000 | 0.09% |
| McQueen, Ball & Associates Inc. | 102,742 | $36,000 | 0.03% |
| Sheaff Brock Investment Advisors, LLC | 320,000 | $113,000 | 0.01% |
| Roundview Capital LLC | 21,100 | $7,000 | 0.00% |
| QCM Cayman, Ltd. | 11,197 | $4,000 | 0.00% |
| ZACKS INVESTMENT MANAGEMENT | 193,406 | $68,000 | 0.00% |
| Renaissance Technologies | 2,504,200 | $881,000 | 0.00% |
| Squarepoint Ops LLC | 56,800 | $20,000 | 0.00% |